📣 Register now to attend EPHA’s 6th Access to Medicines Forum!
The #A2MForum, hosted annually by EPHA, serves as a platform for facilitating discussions regarding pharmaceutical and medicine policies in the Brussels area and beyond.
The revision of the #pharmaceutical #legislation is a pivotal moment that could pave the way to addressing the crucial balance between public interests for affordable, safe medicines and private sector innovation. At the A2M Forum, we're diving into these changes' implications, especially concerning antibiotic development, access, and fair pricing—the very heart of our discussions.
In this 6th edition of the Forum, we will therefore delve into the need for more effective and fair incentives to promote new antibiotic development and securing access to existing ones. We will also discuss ways forward to improve transparency of pharmaceutical R&D costs to ensure #FairMedicinePrices.
The forum is an opportunity for diverse stakeholders – including patients, healthcare professionals, payers, European policymakers, health law experts – to engage in dialogues, crafting more effective, equitable, and transparent pharmaceutical policies.
We will be joined by ten distinguished speakers who will each contribute to the discussion from their own unique perspective. Don't miss the opportunity to participate in this impactful conversation!
📅 8th December, 9.30AM - 1PM
📍Scotland House Brussels, Roundabout Robert Schuman 6, 1040 Brussels, Belgium
📝 There is limited capacity for in-person attendance, so register now ⏩ https://lnkd.in/d2hEWWsm
Pharmacogenomics Specialist
2wWould you be doing a module on CYP2D6 genotyping for Codeine prescription at some point as well in your webinar series?